Proteins > 5-hydroxytryptamine receptor 4
Page last updated: 2024-08-07 17:06:18
5-hydroxytryptamine receptor 4
A 5-hydroxytryptamine receptor 4 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q13639]
Synonyms
5-HT-4;
5-HT4;
Serotonin receptor 4
Research
Bioassay Publications (43)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 1 (2.33) | 18.7374 |
1990's | 3 (6.98) | 18.2507 |
2000's | 19 (44.19) | 29.6817 |
2010's | 18 (41.86) | 24.3611 |
2020's | 2 (4.65) | 2.80 |
Compounds (35)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
metergoline | Homo sapiens (human) | Activity | 1.2740 | 1 | 1 |
gr 113808 | Homo sapiens (human) | Kb | 0.0000 | 1 | 1 |
Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic properties.Bioorganic & medicinal chemistry letters, , Jul-15, Volume: 23, Issue:14, 2013
Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior.Journal of medicinal chemistry, , May-22, Volume: 46, Issue:11, 2003
Discovery and pharmacological profile of new hydrophilic 5-HT(4) receptor antagonists.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 24, Issue:18, 2014
Acidic biphenyl derivatives: synthesis and biological activity of a new series of potent 5-HT(4) receptor antagonists.Bioorganic & medicinal chemistry, , Nov-15, Volume: 21, Issue:22, 2013
Synthesis and pharmacological properties of a new hydrophilic and orally bioavailable 5-HT4 antagonist.European journal of medicinal chemistry, , Volume: 64, 2013
Discovery and pharmacological profile of new 1H-indazole-3-carboxamide and 2H-pyrrolo[3,4-c]quinoline derivatives as selective serotonin 4 receptor ligands.Journal of medicinal chemistry, , Nov-26, Volume: 55, Issue:22, 2012
Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.Bioorganic & medicinal chemistry, , Dec-15, Volume: 18, Issue:24, 2010
Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.Bioorganic & medicinal chemistry, , Mar-15, Volume: 17, Issue:6, 2009
Synthesis of specific bivalent probes that functionally interact with 5-HT(4) receptor dimers.Journal of medicinal chemistry, , Sep-06, Volume: 50, Issue:18, 2007
New arylpiperazine derivatives as antagonists of the human cloned 5-HT(4) receptor isoforms.Journal of medicinal chemistry, , Oct-05, Volume: 43, Issue:20, 2000
Discovery and pharmacological profile of new hydrophilic 5-HT(4) receptor antagonists.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 24, Issue:18, 2014
Acidic biphenyl derivatives: synthesis and biological activity of a new series of potent 5-HT(4) receptor antagonists.Bioorganic & medicinal chemistry, , Nov-15, Volume: 21, Issue:22, 2013
Synthesis and pharmacological properties of a new hydrophilic and orally bioavailable 5-HT4 antagonist.European journal of medicinal chemistry, , Volume: 64, 2013
Discovery and pharmacological profile of new 1H-indazole-3-carboxamide and 2H-pyrrolo[3,4-c]quinoline derivatives as selective serotonin 4 receptor ligands.Journal of medicinal chemistry, , Nov-26, Volume: 55, Issue:22, 2012
Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.Bioorganic & medicinal chemistry, , Dec-15, Volume: 18, Issue:24, 2010
Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.Bioorganic & medicinal chemistry, , Mar-15, Volume: 17, Issue:6, 2009
Identification of a 5-HT4 receptor antagonist clinical candidate through side-chain modification.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 15, Issue:6, 2005
N-[(1-butyl-4-piperidinyl)methyl]-3,4dihydro-2H-[1,3]oxazino[3,2- a]indole10-carboxamide hydrochloride: the first potent and selective 5-HT4 receptor antagonist amide with oral activity.Journal of medicinal chemistry, , Nov-24, Volume: 38, Issue:24, 1995
Synthesis, Structure-Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HTJournal of medicinal chemistry, , 06-14, Volume: 61, Issue:11, 2018
Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.European journal of medicinal chemistry, , Oct-20, Volume: 103, 2015
Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.Bioorganic & medicinal chemistry, , Mar-15, Volume: 17, Issue:6, 2009
5-HT4 receptor ligands: applications and new prospects.Journal of medicinal chemistry, , Jan-30, Volume: 46, Issue:3, 2003
Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent.European journal of medicinal chemistry, , Feb-15, Volume: 109, 2016
Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.Bioorganic & medicinal chemistry letters, , Oct-01, Volume: 22, Issue:19, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749.Bioorganic & medicinal chemistry letters, , Jul-15, Volume: 22, Issue:14, 2012
Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.European journal of medicinal chemistry, , Oct-20, Volume: 103, 2015
Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease.Journal of medicinal chemistry, , Apr-23, Volume: 52, Issue:8, 2009
Synthesis of specific bivalent probes that functionally interact with 5-HT(4) receptor dimers.Journal of medicinal chemistry, , Sep-06, Volume: 50, Issue:18, 2007
Design and synthesis of specific probes for human 5-HT4 receptor dimerization studies.Journal of medicinal chemistry, , Oct-06, Volume: 48, Issue:20, 2005
Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.Journal of medicinal chemistry, , Jun-19, Volume: 46, Issue:13, 2003
New arylpiperazine derivatives as antagonists of the human cloned 5-HT(4) receptor isoforms.Journal of medicinal chemistry, , Oct-05, Volume: 43, Issue:20, 2000
Discovery of G Protein-Biased Antagonists against 5-HTJournal of medicinal chemistry, , 09-23, Volume: 64, Issue:18, 2021
A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).Journal of medicinal chemistry, , Feb-10, Volume: 43, Issue:3, 2000
Design, synthesis and evaluation of 2-(2-oxoethyl)pyrimidine-5-carboxamide derivatives as acetylcholinesterase inhibitors.Bioorganic & medicinal chemistry letters, , 09-15, Volume: 72, 2022
Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease.European journal of medicinal chemistry, , May-01, Volume: 169, 2019
Novel multitarget-directed ligands targeting acetylcholinesterase and σEuropean journal of medicinal chemistry, , Jan-15, Volume: 162, 2019
Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride.Journal of medicinal chemistry, , Apr-09, Volume: 58, Issue:7, 2015
Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic properties.Bioorganic & medicinal chemistry letters, , Jul-15, Volume: 23, Issue:14, 2013
Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.Bioorganic & medicinal chemistry letters, , Oct-01, Volume: 22, Issue:19, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749.Bioorganic & medicinal chemistry letters, , Jul-15, Volume: 22, Issue:14, 2012
Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.Bioorganic & medicinal chemistry, , Mar-15, Volume: 17, Issue:6, 2009
Brominated cyclodipeptides from the marine sponge Geodia barretti as selective 5-HT ligands.Journal of natural products, , Volume: 69, Issue:10, 2006
Enables
This protein enables 4 target(s):
Target | Category | Definition |
G protein-coupled serotonin receptor activity | molecular function | Combining with the biogenic amine serotonin and transmitting the signal across the membrane by activating an associated G-protein. Serotonin (5-hydroxytryptamine) is a neurotransmitter and hormone found in vertebrates and invertebrates. [GOC:ai] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
serotonin receptor activity | molecular function | Combining with the biogenic amine serotonin and transmitting a signal across a membrane by activating some effector activity. Serotonin (5-hydroxytryptamine) is a neurotransmitter and hormone found in vertebrates and invertebrates. [GOC:dos] |
neurotransmitter receptor activity | molecular function | Combining with a neurotransmitter and transmitting the signal to initiate a change in cell activity. [GOC:jl, GOC:signaling] |
Located In
This protein is located in 5 target(s):
Target | Category | Definition |
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
endosome | cellular component | A vacuole to which materials ingested by endocytosis are delivered. [ISBN:0198506732, PMID:19696797] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
membrane | cellular component | A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it. [GOC:dos, GOC:mah, ISBN:0815316194] |
synapse | cellular component | The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. [GOC:aruk, ISBN:0198506732, PMID:24619342, PMID:29383328, PMID:31998110] |
Active In
This protein is active in 2 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
dendrite | cellular component | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. [GOC:aruk, GOC:bc, GOC:dos, GOC:mah, GOC:nln, ISBN:0198506732] |
Involved In
This protein is involved in 9 target(s):
Target | Category | Definition |
G protein-coupled receptor signaling pathway | biological process | The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane. [GOC:bf, GOC:mah, PMID:16902576, PMID:24568158, Wikipedia:G_protein-coupled_receptor] |
maintenance of gastrointestinal epithelium | biological process | Protection of epithelial surfaces of the gastrointestinal tract from proteolytic and caustic digestive agents. [GOC:mah] |
regulation of appetite | biological process | Any process which modulates appetite, the desire or physical craving for food. [GOC:add] |
mucus secretion | biological process | The regulated release of mucus by the mucosa. Mucus is a viscous slimy secretion consisting of mucins and various inorganic salts dissolved in water, with suspended epithelial cells and leukocytes. The mucosa, or mucous membrane, is the membrane covered with epithelium that lines the tubular organs of the body. Mucins are carbohydrate-rich glycoproteins that have a lubricating and protective function. [GOC:add, ISBN:068340007X, ISBN:0721662544] |
G protein-coupled serotonin receptor signaling pathway | biological process | The series of molecular signals generated as a consequence of a G protein-coupled serotonin receptor binding to one of its physiological ligands. [GOC:mah] |
large intestinal transit | biological process | Migration of ingested material along the length of the large intestine. [GOC:sl, PMID:28157109] |
adenylate cyclase-modulating G protein-coupled receptor signaling pathway | biological process | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation or inhibition of adenylyl cyclase activity and a subsequent change in the intracellular concentration of cyclic AMP (cAMP). [GOC:mah, GOC:signaling, ISBN:0815316194] |
chemical synaptic transmission | biological process | The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. [GOC:jl, MeSH:D009435] |
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | biological process | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation or inhibition of a nucleotide cyclase activity and a subsequent change in the concentration of a cyclic nucleotide. [GOC:mah, GOC:signaling, ISBN:0815316194] |